Literature DB >> 26140040

Rapidly Progressive Cardiac Failure Due to Giant Cell Myocarditis: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery.

Ersilia M DeFilippis1, Sonali Narain2, Irina Sobol1, Navneet Narula3, Anne Bass2, Doruk Erkan2.   

Abstract

Entities:  

Keywords:  autoimmune disorder; giant cell myocarditis

Year:  2015        PMID： 26140040      PMCID： PMC4481256          DOI： 10.1007/s11420-015-9449-5

Source DB:  PubMed          Journal:  HSS J        ISSN： 1556-3316


× No keyword cloud information.
  18 in total

1.  Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults.

Authors:  Riina Kandolin; Jukka Lehtonen; Markku Kupari
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-03-22

Review 2.  Giant cell and granulomatous myocarditis.

Authors:  Leslie T Cooper
Journal:  Heart Fail Clin       Date:  2005-10       Impact factor: 3.179

3.  Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis.

Authors:  Lindsay K Murray; Jose González-Costello; Samual N Jonas; Daniel B Sims; Kerry A Morrison; Paolo C Colombo; Donna M Mancini; Susan W Restaino; Evan Joye; Evelyn Horn; Hiroo Takayama; Charles C Marboe; Yoshifumi Naka; Ulrich P Jorde; Nir Uriel
Journal:  Eur J Heart Fail       Date:  2012-01-20       Impact factor: 15.534

4.  Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators.

Authors:  L T Cooper; G J Berry; R Shabetai
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

5.  Heart transplantation for giant cell myocarditis.

Authors:  D K Cooper; R G Schlesinger; S Shrago; N Zuhdi
Journal:  J Heart Lung Transplant       Date:  1994 May-Jun       Impact factor: 10.247

6.  Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression.

Authors:  Riina Kandolin; Jukka Lehtonen; Kaisa Salmenkivi; Anne Räisänen-Sokolowski; Jyri Lommi; Markku Kupari
Journal:  Circ Heart Fail       Date:  2012-11-13       Impact factor: 8.790

7.  A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction.

Authors:  M Kodama; Y Matsumoto; M Fujiwara; F Masani; T Izumi; A Shibata
Journal:  Clin Immunol Immunopathol       Date:  1990-11

Review 8.  Giant cell myocarditis: most fatal of autoimmune diseases.

Authors:  E D Rosenstein; M J Zucker; N Kramer
Journal:  Semin Arthritis Rheum       Date:  2000-08       Impact factor: 5.532

9.  IgG anti-cardiomyocyte antibodies in giant cell myocarditis.

Authors:  Kim HooKim; Stephen deRoux; Anne Igbokwe; Albert Stanek; Jaik Koo; Jean Hsu; Matthew R Pincus; Martin H Bluth
Journal:  Ann Clin Lab Sci       Date:  2008       Impact factor: 1.256

10.  Anti-alpha beta T cell receptor antibody prevents the progression of experimental autoimmune myocarditis.

Authors:  H Hanawa; M Kodama; T Inomata; T Izumi; A Shibata; M Tuchida; Y Matsumoto; T Abo
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330
View more
  1 in total

Review 1.  A model-informed approach to assess the risk of immune checkpoint inhibitor-induced autoimmune myocarditis.

Authors:  Solveig A van der Vegt; Ying-Jie Wang; Liudmila Polonchuk; Ken Wang; Sarah L Waters; Ruth E Baker
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.